This virtual roundtable will explore the challenges and opportunities facing companies developing oncology and rare disease products during the COVID-19 pandemic. Parexel will be joined by Sara’s Cure, a Clear Cell Sarcoma patient advocacy group and charitable foundation.

The panelists will discuss:

• Patient experiences of the pandemic
• Patient perspectives on participating in research during the pandemic
• Considerations for development strategy for oncology and rare disease programs at this time
• Working with global health authorities for smoother start-up of research programs during COVID-19